BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 10588963)

  • 1. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
    Poldermans D; Boersma E; Bax JJ; Thomson IR; van de Ven LL; Blankensteijn JD; Baars HF; Yo TI; Trocino G; Vigna C; Roelandt JR; van Urk H
    N Engl J Med; 1999 Dec; 341(24):1789-94. PubMed ID: 10588963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.
    Poldermans D; Boersma E; Bax JJ; Thomson IR; Paelinck B; van de Ven LL; Scheffer MG; Trocino G; Vigna C; Baars HF; van Urk H; Roelandt JR;
    Eur Heart J; 2001 Aug; 22(15):1353-8. PubMed ID: 11465968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
    Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing cardiac risk in noncardiac surgery.
    Lee TH
    N Engl J Med; 1999 Dec; 341(24):1838-40. PubMed ID: 10588971
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
    Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A
    Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.
    Kertai MD; Boersma E; Westerhout CM; Klein J; Van Urk H; Bax JJ; Roelandt JR; Poldermans D
    Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):343-52. PubMed ID: 15350554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.
    Boersma E; Poldermans D; Bax JJ; Steyerberg EW; Thomson IR; Banga JD; van De Ven LL; van Urk H; Roelandt JR;
    JAMA; 2001 Apr; 285(14):1865-73. PubMed ID: 11308400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Mar; 49(3):203-4. PubMed ID: 10735475
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-blockade and surgery.
    Prichard BN; Robin JM
    Eur Heart J; 2001 Aug; 22(15):1253-5. PubMed ID: 11465960
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
    Schouten O; Poldermans D; Visser L; Kertai MD; Klein J; van Urk H; Simoons ML; van de Ven LL; Vermeulen M; Bax JJ; Lameris TW; Boersma E
    Am Heart J; 2004 Dec; 148(6):1047-52. PubMed ID: 15632892
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blockade for patients undergoing vascular surgery.
    Litwack RS; Gilligan DM; DeGruttola V
    N Engl J Med; 2000 Apr; 342(14):1052; author reply 1052-3. PubMed ID: 10755897
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.
    Mangano DT; Layug EL; Wallace A; Tateo I
    N Engl J Med; 1996 Dec; 335(23):1713-20. PubMed ID: 8929262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery.
    London MJ; Hur K; Schwartz GG; Henderson WG
    JAMA; 2013 Apr; 309(16):1704-13. PubMed ID: 23613075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
    Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockade for patients undergoing vascular surgery.
    Feldman T; Fusman B; McKinsey JF
    N Engl J Med; 2000 Apr; 342(14):1051-2; author reply 1052-3. PubMed ID: 10755896
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
    Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
    Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery.
    Marwick TH; Branagan H; Venkatesh B; Stewart S;
    Am Heart J; 2009 Apr; 157(4):784-90. PubMed ID: 19332211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery.
    Feringa HH; Bax JJ; Schouten O; Poldermans D
    Semin Cardiothorac Vasc Anesth; 2006 Mar; 10(1):25-31. PubMed ID: 16703231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery.
    Poldermans D; Arnese M; Fioretti PM; Boersma E; Thomson IR; Rambaldi R; van Urk H
    Circulation; 1997 Jan; 95(1):53-8. PubMed ID: 8994416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.